Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06932705 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Compare to PK Characteristics and Safety Profiles Between PA-111 and PA-111A

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 17, 2025 (before its estimated May 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
Addpharma Inc.
28 trials monitored
See 1 trial at risk
Primary endpoint of this study is to evaluate the pharmacokinetic characteristics of PA-111 in healthy subjects.
Trial Details
NCT Number NCT06932705
Lead Sponsor Addpharma Inc.
Conditions
(from sponsor)		 Mixed Dyslipidemia
Enrollment 48 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov